Skip to main content

Table 2 Mortality and location of death in patients with and without systemic anti-cancer treatment

From: Intensity of end-of-life health care and mortality after systemic anti-cancer treatment in patients with advanced lung cancer

 

SACT

(N = 489)

No-SACT

(N = 289)

Died ≤14 days since MDT, N (%)

4 (0.8)

68 (23.5)

Died ≤30 days since MDT, N (%)

12 (2.5)

118 (40.8)

Died ≤30 days since last cycle, N (%)

72 (14.7)

NA

Died at data cut off, N (%)

376 (76.9)

279 (96.5)

Place of death

 Acute care hospitala

144 (38.3)

41 (14.2)

 Following ED attendance b

82 (21.8)

28 (9.7)

 Nursing home

90 (23.9)

20 (6.9)

 Out-of-hospital

142 (37.8)

218 (75.4)

  1. Abbreviations: SACT Systemic anti-cancer treatment, ED Emergency department
  2. aDied at hospital when the date of last claim was the date of death plus 1 day
  3. bDied at hospital through ED visit when the last claim started with the date of ED claim. 9 patients in the no-SACT arm and 30 patients in the SACT arm died on same or next day as ED visit
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us